
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Following the merger between INC Research and inVentiv Health, which created a fully integrated biopharmaceutical solutions organization that combined a CRO and CCO, it has been announced that they have changed their brand identity to Syneos Health, Inc. The new brand will combine commercial and clinical solutions to accelerate customer performance.
Read the full release






